HLB Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14,476	13,291	52,725	16,769	30,978	31,254
Short-Term Investments	5,273	586.88	16,212	11,298	12,350	24,690
Trading Asset Securities	-	-	10,629	50,793	88,661	84,017
Cash & Short-Term Investments	19,748	13,878	79,566	78,860	131,989	139,961
Cash Growth	-69.10%	-82.56%	0.90%	-40.25%	-5.70%	-11.44%
Accounts Receivable	18,277	14,975	18,120	11,464	13,072	11,648
Other Receivables	640.92	1,906	2,057	2,371	2,116	1,123
Receivables	19,921	22,884	20,188	14,646	16,202	14,157
Inventory	5,860	6,791	6,103	5,267	10,867	1,769
Prepaid Expenses	862.66	1,081	468.69	448.74	208.4	281.34
Other Current Assets	1,008	1,004	1,382	238.85	1,509	654.91
Total Current Assets	47,400	45,637	107,709	99,460	160,776	156,822
Property, Plant & Equipment	130,531	129,753	81,206	72,918	92,089	22,081
Long-Term Investments	231,085	226,153	254,694	146,038	44,749	24,346
Goodwill	-	8,275	-	1,772	21,925	-
Other Intangible Assets	51,240	43,338	44,780	54,029	69,506	62,809
Long-Term Accounts Receivable	-	-	-	-	341.17	363.96
Long-Term Deferred Charges	-	125.91	-	-	-	-
Other Long-Term Assets	24,601	24,676	50,500	49,158	22,264	4,262
Total Assets	485,003	478,094	539,017	423,500	411,790	270,800
Accounts Payable	2,606	2,682	6,985	5,160	9,384	10,278
Accrued Expenses	2,499	2,819	2,029	2,240	697.15	717.82
Short-Term Debt	89,291	84,727	28,153	106,761	7,920	-
Current Portion of Long-Term Debt	18,194	18,380	12,276	7,060	387.2	-
Current Portion of Leases	650.16	920.17	632.14	922.33	2,145	668
Current Income Taxes Payable	92.36	177.53	52.6	7,555	132.13	-
Current Unearned Revenue	-	-	2.91	31.49	38.42	24.01
Other Current Liabilities	15,773	9,111	3,417	5,727	6,081	1,848
Total Current Liabilities	129,106	118,815	53,547	135,457	26,785	13,536
Long-Term Debt	53,917	54,473	82,529	51,410	136,189	3,500
Long-Term Leases	2,013	1,857	193.33	424.01	832.41	452.62
Pension & Post-Retirement Benefits	746.21	709.14	568.2	615.57	683.58	716.65
Long-Term Deferred Tax Liabilities	2,921	2,208	2,310	3,345	10,033	5,758
Other Long-Term Liabilities	2,318	2,288	1,045	1,036	1,201	224.73
Total Liabilities	191,023	180,351	140,192	192,288	175,724	24,188
Common Stock	61,432	61,432	61,416	51,407	48,831	48,223
Additional Paid-In Capital	320,197	320,197	319,343	168,141	222,910	240,895
Retained Earnings	-91,212	-83,416	16,373	10,431	-40,963	-46,832
Treasury Stock	-679.97	-679.97	-679.97	-679.97	-	-
Comprehensive Income & Other	3,863	-182	1,889	1,499	3,947	3,904
Total Common Equity	293,601	297,351	398,340	230,797	234,725	246,189
Minority Interest	379.68	390.84	484.91	416.21	1,342	422.87
Shareholders' Equity	293,981	297,742	398,825	231,213	236,067	246,612
Total Liabilities & Equity	485,003	478,094	539,017	423,500	411,790	270,800
Total Debt	164,066	160,357	123,783	166,578	147,473	4,621
Net Cash (Debt)	-144,318	-146,479	-44,217	-87,718	-15,484	135,340
Net Cash Growth	-	-	-	-	-	-7.71%
Net Cash Per Share	-1183.45	-1201.75	-396.21	-861.84	-153.36	1362.33
Filing Date Shares Outstanding	121.81	121.85	121.81	101.8	96.71	100.44
Total Common Shares Outstanding	121.81	121.85	121.81	101.8	101.71	100.44
Working Capital	-81,706	-73,179	54,162	-35,997	133,991	143,286
Book Value Per Share	2410.40	2440.36	3270.06	2267.23	2307.67	2451.22
Tangible Book Value	242,361	245,738	353,561	174,996	143,294	183,380
Tangible Book Value Per Share	1989.73	2016.78	2902.45	1719.07	1408.78	1825.85
Land	-	27,490	21,569	21,471	29,580	9,065
Buildings	-	51,362	23,221	23,221	19,950	4,547
Machinery	-	75,805	40,056	39,219	30,949	12,906
Construction In Progress	-	1,243	33,101	8,472	18,390	1,324